CIK: 1637054 - Address: C/O Black Diamond Therapeutics, Inc., One Main Street, 14Th Floor, Cambridge, MA 02142
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

5/13/21 16:53
5/12/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-11227.420-4-338D
4/13/21 20:45
4/12/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-10225.000-4-338D
3/16/21 16:56
3/12/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-10726.360-4-338D
2/12/21 21:24
2/12/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-11127.230-4-338D
1/14/21 20:57
1/12/21
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-39434.030-12-588D
12/16/20 19:41
12/14/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-14334.950-4-583D
11/13/20 16:25
11/12/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-13933.990-4-583D
10/14/20 16:32
10/12/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-13332.700-4-583D
9/16/20 18:11
9/14/20
BDTXBlack Diamond Therapeutics, Inc.DEHealthBioPrdBiological Products, (No DiagHatzis-Schoch BrentMAOSee RemaS.d-12731.040-4-583D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact